Capitainer announces collaboration with AstraZeneca
The Swedish medtech company Capitainer AB today announces a research collaboration with AstraZeneca. AstraZeneca R&D Gothenburg will use a novel device from Capitainer to develop protocols for biomarkers relevant to AstraZeneca’s clinical drug programs.
Taggar: capitainer, announces, collaboration
Läs hela artikeln på Dagens industri